Insider Shareholders with Direct Ownership of Adial Pharmaceuticals, Inc. (ADIL)
This section provides a comprehensive overview of the insiders with direct ownership of Adial Pharmaceuticals, Inc. (ADIL). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
ADIAL PHARMACEUTICALS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Cary J Claiborne
Chief Executive Officer |
1,520,000 | 0 | 1,520,000 $1.63 Million | 4 |
May 23, 2023
Added 21.65%
|
|
William B. Stilley Iii
Director |
712,509 | 166,667 | 1,261,779 $1.35 Million | 6 |
May 23, 2023
Added 16.03%
|
|
Joseph Truluck
Chief Financial Officer |
157,500 | 0 | 265,139 $283,698 | 1 |
May 23, 2023
Added 37.27%
|
|
James W. Newman Jr.
Director |
10,000 | 0 | 20,000 $21,400 | 1 |
Dec 30, 2021
Added 33.33%
|
|
Kevin Schuyler
Director |
700 | 312,990 | 700 $749 | 2 |
Sep 29, 2023
Added 50.0%
|